Suzhou Medsys Tech Co Ltd (603990) — Cash Flow Reinvestment Rate
Suzhou Medsys Tech Co Ltd (603990) has a Cash Flow Reinvestment Rate of 0.60x as of September 2025, reinvesting CN¥10.62 Million (capex CN¥10.62 Million ) from operating cash flow of CN¥17.84 Million. Check Suzhou Medsys Tech Co Ltd (603990) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Suzhou Medsys Tech Co Ltd Cash Flow Reinvestment Rate (2012–2022)
Historical reinvestment intensity for Suzhou Medsys Tech Co Ltd across 10 annual periods. Explore 603990 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Suzhou Medsys Tech Co Ltd (2012–2022)
Year-by-year capital reinvestment analysis for Suzhou Medsys Tech Co Ltd. For live market cap and broader valuation context, see Suzhou Medsys Tech Co Ltd (603990) total market value.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 4.55x | CN¥229.90 Million | CN¥50.51 Million | CN¥24.58 Million | ▼ -56.7% |
| 2021 | 10.52x | CN¥379.06 Million | CN¥36.04 Million | CN¥40.99 Million | ▲ +11796.8% |
| 2020 | 0.09x | CN¥8.88 Million | CN¥100.48 Million | CN¥8.88 Million | ▼ -90.0% |
| 2019 | 0.89x | CN¥19.57 Million | CN¥22.04 Million | CN¥12.89 Million | ▼ -29.9% |
| 2018 | 1.27x | CN¥61.62 Million | CN¥48.67 Million | CN¥16.62 Million | ▼ -64.7% |
| 2016 | 3.59x | CN¥116.80 Million | CN¥32.56 Million | CN¥28.01 Million | ▲ +68.5% |
| 2015 | 2.13x | CN¥79.94 Million | CN¥37.54 Million | CN¥79.94 Million | ▲ +38.9% |
| 2014 | 1.53x | CN¥62.59 Million | CN¥40.82 Million | CN¥62.59 Million | ▲ +139.5% |
| 2013 | 0.64x | CN¥21.03 Million | CN¥32.84 Million | CN¥21.03 Million | ▲ +193.0% |
| 2012 | 0.22x | CN¥2.37 Million | CN¥10.83 Million | CN¥2.37 Million | — |